Limited duration of dexamethasone in newly diagnosed AL amyloidosis: impact on response, toxicity, and survival
{{output}}
Background: Systemic light chain amyloidosis (AL) is a life-threatening disease in which dexamethasone (Dex) is a core therapy but is limited by cumulative toxicity. The optimal duration of Dex, particularly in the era of daratum... ...
